2,099 results on '"Matucci‐Cerinic, M."'
Search Results
2. The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review
3. Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
4. Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort
5. POS0821 MENOPAUSE AND SYSTEMIC SCLEROSIS: THE LINK BETWEEN MENOPAUSAL AGE, DISEASE ONSET AND CLINICAL MANIFESTATIONS IN AN ANALYSIS OF THE SPRING-SIR REGISTRY
6. AB1070 DISTINCTIVE TRAITS OF INFECTION-TRIGGERED FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PRELIMINARY DATA FROM A MONOCENTRIC COHORT
7. AB1056 ACCELERATED DAMAGE ACCRUAL IN PATIENTS WITH LONG-STANDING SLE RECEIVING GLUCOCORTICOIDS
8. AB1183 THE USE OF MYCOPHENOLATE MOFETIL IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS IS ASSOCIATED WITH A REDUCED RISK OF VASCULAR COMPLICATIONS REQUIRING PHARMACOLOGICAL INTERVENTION UPGRADES
9. POS1479-HPR TRAVEL DISTANCE TO TERTIARY HEALTHCARE REFLECTS DISEASE SEVERITY AND MEDICATION ACCESS IN SYSTEMIC SCLEROSIS PATIENTS: INSIGHTS FROM THE ITALIAN SPRING REGISTRY
10. POS0235 NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: CLINICAL COURSE AND OUTCOMES FROM A EUSTAR DATABASE ANALYSIS
11. POS0211 PAH TREATMENT AT TIME OF DIAGNOSIS IS ASSOCIATED WITH IMPROVED SURVIVAL REGARDLESS OF HEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION - A EUSTAR ANALYSIS
12. POS1099 DIFFICULT-TO-TREAT MANIFESTATIONS OF GRANULOMATOSIS WITH POLYANGIITIS. A EUROPEAN MULTICENTRE STUDY ON SUBGLOTTIC STENOSIS
13. AB1196 BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN SUBJECTS WITH ILD IN A PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF MT-7117 IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
14. AB1189 THE CIRCULATING LEVELS OF ENDOGENOUS EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID-DERIVED RESOLVINS ARE INCREASED IN SYSTEMIC SCLEROSIS: EVIDENCE FROM A SINGLE CENTRE COHORT
15. POS0832 IMMUNOSUPPRESSION VERSUS COMBINATION OF IMMUNOSUPPRESSION AND ORAL GLUCOCORTICOIDS FOR SKIN FIBROSIS IN EARLY DIFFUSE SYSTEMIC SCLEROSIS PATIENTS. A TARGET TRIAL EMULATION STUDY FROM THE EUSTAR DATABASE
16. POS1101 IL5 MODULATION AND THROMBOTIC RISK IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A PROOF-OF-CONCEPT MONOCENTRIC STUDY
17. AB1300 AGE AT DISEASE ONSET INFLUENCES THE CLINICAL PHENOTYPE AND OUTCOME OF PATIENTS WITH TAKAYASU ARTERITIS: RESULTS FROM A MONOCENTRIC COHORT OF 167 PATIENTS
18. AB0212 SECUKINUMAB IN PATIENTS WITH SPONDYLARTHRITIS AND A HISTORY OF MALIGNANCY: EXPERIENCE FROM A LARGE MONOCENTRIC COHORT
19. POS0842 PRIMARY HEART INVOLVEMENT IN SYSTEMIC SCLEROSIS: THE ROLE OF VENTRICULAR ECTOPIC BEATS AS RED FLAGS FOR ACTIVE MYOCARDIAL INFLAMMATION DETECTED AT CARDIAC MAGNETIC RESONANCE
20. POS0044 DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION
21. OP0265 RITUXIMAB RETENTION RATE IN SYSTEMIC SCLEROSIS: A REAL-LIFE ITALIAN MULTICENTER STUDY
22. OP0225 CHANGES IN TREATMENT PATTERNS AND THEIR INFLUENCE ON THE OUTCOME OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD) PATIENTS: AN EUSTAR ANALYSIS
23. POS0826 PREDICTORS OF RESPONSE AND LONG-TERM EFFICACY AND SAFETY OF NINTEDANIB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE: DATA FROM AN ITALIAN MULTICENTRE STUDY
24. POS0425 SUBCLINICAL LOSS OF LUNG VOLUMES IN VERY EARLY SSc: EVIDENCE FROM THE VEDOSS DATABASE
25. OP0073 UNRAVELING PATHOPHYSIOLOGY AND HEMATOPOIESIS OF VEXAS SYNDROME BY MULTI-OMICS ANALYSIS AND TARGETED GENE EDITING
26. POS0843 IMMUNOSUPPRESSIVE THERAPY TO TREAT NEWLY DIAGNOSED PRIMARY HEART INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN ITALIAN CARDIAC MAGNETIC RESONANCE BASED STUDY
27. AB0201 RETENTION RATES OF DIFFERENT JANUS KINASES INHIBITORS IN RHEUMATOID ARTHRITIS: EXPERIENCE FROM A LARGE MONOCENTRIC COHORT
28. POS0845 PREDICTORS OF PRIMARY HEART INVOLVEMENT DEFINED BY CARDIAC MAGNETIC RESONANCE IN SYSTEMIC SCLEROSIS
29. POS1483-HPR THE TELEMEDICINE HETEROGENEITY IN RHEUMATIC AND MUSCULOSKELETAL DISEASES: A SCOPING REVIEW
30. POS0432 DRIVERS OF DISEASE BURDEN IN PATIENTS WITH SYSTEMIC SCLEROSIS ACROSS CLINICAL AND DEMOGRAPHIC SUBGROUPS REVEALED BY THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (ScleroID) QUESTIONNAIRE
31. The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis
32. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
33. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology
34. Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience.
35. Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck
36. Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis
37. POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY?
38. AB0898 LUNG ULTRASONOGRAPHY FOR THE SCREENING AND PROGNOSTIC STRATIFICATION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
39. AB0771 FEMALE GENDER AND STEROID TREATMENT AS MAIN INFLUENCING FACTORS IN THE PERCEPTION OF QUALITY OF LIFE IN ANCA-ASSOCIATED VASCULITIS: FINAL RESULTS FROM THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE
40. AB0808 A PROOF OF BIOLOGICAL CONCEPT TRIAL OF CM101 TO TARGET CCL24 IN SYSTEMIC SCLEROSIS: A BIOMARKER INFORMED, PRECISION MEDICINE APPROACH
41. POS1275 THE HETEROGENEITY OF DEFINING SEVERITY, PROGRESSION AND OUTCOMES IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
42. POS0463 ASSOCIATION OF CIRCULATING LEVELS OF ANTI-CARP ANTIBODIES WITH DISEASE ACTIVITY AND RADIOLOGICAL DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS
43. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
44. POS1313 EFFICACY OF IMMUNOGLOBULIN TREATMENT ON GASTROINTESTINAL, CUTANEOUS AND VASCULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS: DATA FROM AN ITALIAN COHORT OF 65 PATIENTS
45. OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
46. POS1263 SMOKING INFLUENCE ON AUTOANTIBODY PROFILE AND DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS: AN EUSTAR DATABASE ANALYSIS
47. POS1278 SAFETY AND PHARMACOKINETICS OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) AND IGPRO10 (INTRAVENOUS IMMUNOGLOBULIN) IN ADULTS WITH SYSTEMIC SCLEROSIS (SSC) – RESULTS FROM A PHASE 2 TRIAL
48. POS0121 COMPARISON OF FOUR RISK STRATIFICATION MODELS FOR PREDICTION OF MORTALITY IN SSc-PAH IN THE EUSTAR COHORT
49. POS1587-HPR DISABILITY IN AN ITALIAN COHORT OF RHEUMATIC DISEASES: A MIXED METHOD STUDY FOR THE ANALYSIS OF THE PHENOMENON AND PROPOSALS FOR NURSING APPROACH
50. POS1057 LUNG ULTRASONOGRAPHY AS A SCREENING TOOL FOR INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.